Vaccine delivery is a critical aspect of immunization programs, focusing on methods to administer vaccines effectively and safely to target populations. Traditional vaccine delivery methods include intramuscular or subcutaneous injections, widely used for routine immunizations. More recently, advances in needle-free technologies, such as jet injectors and microneedle patches, aim to improve vaccine accessibility and reduce pain associated with injections. Oral vaccines, administered through the mouth, offer a convenient and non-invasive alternative, particularly advantageous for mass vaccination campaigns. Intranasal delivery, using nasal sprays or droplets, targets the mucosal immune system, providing protection at the site of pathogen entry. Cold chain management is crucial for preserving vaccine efficacy during transportation and storage. Innovations like heat-stable vaccines and controlled-release formulations aim to mitigate challenges associated with cold chain requirements, especially in resource-limited settings. The COVID-19 pandemic has witnessed the rapid deployment of novel vaccine delivery approaches, including mRNA vaccines delivered through intramuscular injections and viral vector vaccines. These developments underscore the dynamic nature of vaccine delivery strategies, emphasizing accessibility, ease of administration, and adaptability to diverse healthcare settings. Ongoing research explores innovative delivery technologies to enhance vaccine coverage and address global health challenges.
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Development of a novel multi-component vaccine to address the burden of otitis media in high-risk populations
Ayesha Zahid, Griffith University, Australia
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy
Title : New biomarkers in leishmania major vaccine development
Negar Seyed, Pasteur Institute of Iran, Iran (Islamic Republic of)
Title : Racial disparities in pediatric pneumonia in Brazil: The role of structural racism forging inequalities in acess to vaccines
Livia Daflon Silva, Federal University of State of Rio de Janeiro, Brazil
Title : Approaches towards developing and establishing a biomanufacturing research & development, and manufacturing industry in Zimbabwe: A review of the need, potential funding sources, policy development and implementation
Elliot Nyagumbo, Midlands State University, Zimbabwe